Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' CALLIGARO DO' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 56 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Rasmussen, T; Fink-Jensen, A; Sauerberg, P; Swedberg, MDB; Thomsen, C; Sheardown, MJ; Jeppesen, L; Calligaro, DO; DeLapp, NW; Whitesitt, C; Ward, JS; Shannon, HE; Bymaster, FP
      The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance

      SCHIZOPHRENIA RESEARCH
    2. Xu, YC; Johnson, KW; Phebus, LA; Cohen, M; Nelson, DL; Schenck, K; Walker, CD; Fritz, JE; Kaldor, SW; LeTourneau, ME; Murff, RE; Zgombick, JM; Calligaro, DO; Audia, JE; Schaus, JM
      N-[3-(2-dimethylaminoethyl)-2-methyl-1H-indol-5-yl]-4-fluorobenzamide: A potent, selective, and orally active 5-HT1F receptor agonist potentially useful for migraine therapy

      JOURNAL OF MEDICINAL CHEMISTRY
    3. Bymaster, FP; Carter, PA; DeLapp, NW; Calligaro, DO; Felder, CC
      Receptor reserve of phosphoinositide-coupled muscarinic receptors in mousehippocampus in vivo

      BRAIN RESEARCH
    4. Rasmussen, K; Calligaro, DO; Czachura, JF; Dreshfield-Ahmad, LJ; Evans, DC; Hemrick-Luecke, SK; Kallman, MJ; Kendrick, WT; Leander, JD; Nelson, DL; Overshiner, CD; Wainscott, DB; Wolff, MC; Wong, DT; Branchek, TA; Zgombick, JM; Xu, YC
      The novel 5-hydroxytryptamine(1A) antagonist LY426965: effects on nicotinewithdrawal and interactions with fluoxetine

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    5. Rasmussen, T; Sauerberg, P; Nielsen, EB; Swedberg, MDB; Thomsen, C; Sheardown, MJ; Jeppesen, L; Calligaro, DO; DeLapp, NW; Whitesitt, C; Ward, JS; Shannon, HE; Bymaster, FP; Fink-Jensen, A
      Muscarinic receptor agonists decrease cocaine self-administration rates indrug-naive mice

      EUROPEAN JOURNAL OF PHARMACOLOGY
    6. Bymaster, FP; Nelson, DL; DeLapp, NW; Falcone, JF; Eckols, K; Truex, LL; Foreman, MM; Lucaites, VL; Calligaro, DO
      Antagonism by olanzapine of dopamine D1, serotonin(2), muscarinic, histamine H-1 and alpha(1),-adrenergic receptors in vitro

      SCHIZOPHRENIA RESEARCH
    7. Bymaster, FP; Calligaro, DO; Falcone, JF
      Arachidonic acid release in cell tines transfected with muscarinic receptors: A simple functional assay to determine response of agonists

      CELLULAR SIGNALLING
    8. Sawyer, BD; Bymaster, FP; Calligaro, DO; Falcone, J; Mitch, CH; Ward, JS; Whitesitt, C; Shannon, HE
      Direct pharmacological comparison of the muscarinic receptors mediating relaxation and contraction in the rabbit thoracic aorta

      GENERAL PHARMACOLOGY
    9. Bymaster, FP; Shannon, HE; Rasmussen, K; DeLapp, NW; Ward, JS; Calligaro, DO; Mitch, CH; Whitesitt, C; Ludvigsen, TS; Sheardown, M; Swedberg, M; Rasmussen, T; Olesen, PH; Jeppesen, L; Sauerberg, P; Fink-Jensen, A
      Potential role of muscarinic receptors in schizophrenia

      LIFE SCIENCES
    10. Shannon, HE; Hart, JC; Bymaster, FP; Calligaro, DO; Delapp, NW; Mitch, CH; Ward, JS; Fink-Jensen, A; Sauerberg, P; Jeppesen, L; Sheardown, MJ; Swedberg, MDB
      Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    11. Jeppesen, L; Olesen, PH; Hansen, L; Sheardown, MJ; Thomsen, C; Rasmussen, T; Jensen, AF; Christensen, MS; Rimvall, K; Ward, JS; Whitesitt, C; Calligaro, DO; Bymaster, FP; Delapp, NW; Felder, CC; Shannon, HE; Sauerberg, P
      1-(1,2,5-thiadiazol-4-yl)-4-azatricyclo[2.2.1.0(2,6)]heptanes as new potent muscarinic M-1 agonists: Structure-activity relationship for 3-aryl-2-propyn-1-yloxy and 3-aryl-2-propyn-1-ylthio derivatives

      JOURNAL OF MEDICINAL CHEMISTRY
    12. Bymaster, F; Perry, KW; Nelson, DL; Wong, DT; Rasmussen, K; Moore, NA; Calligaro, DO
      Olanzapine: a basic science update

      BRITISH JOURNAL OF PSYCHIATRY
    13. SAUERBERG P; JEPPESEN L; OLESEN PH; SHEARDOWN MJ; FINKJENSEN A; RASMUSSEN T; RIMVALL K; SHANNON HE; BYMASTER FP; DELAPP NW; CALLIGARO DO; WARD JS; WHITESITT CA; THOMSEN C
      IDENTIFICATION OF SIDE-CHAINS ON 1,2,5-THIADIAZOLE-AZACYCLES OPTIMAL FOR MUSCARINIC M1 RECEPTOR ACTIVATION

      Bioorganic & medicinal chemistry letters
    14. Fink-Jensen, A; Kristensen, P; Shannon, HE; Calligaro, DO; Delapp, NW; Whitesitt, C; Ward, JS; Thomsen, C; Rasmusseen, T; Sheardown, MJ; Jeppesen, L; Sauerberg, P; Bymaster, FP
      Muscarinic agonists exhibit functional dopamine antagonism in unilaterally6-OHDA lesioned rats

      NEUROREPORT
    15. WARD JS; MERRITT L; CALLIGARO DO; BYMASTER FP; SHANNON HE; MITCH CH; WHITESITT C; BRUNSTING D; SHEARDOWN MJ; OLESEN PH; SWEDBERG MDB; JEPPESEN L; SAUERBERG P
      1,2,5-THIADIAZOLE ANALOGS OF ACECLIDINE AS POTENT M(1) MUSCARINIC AGONISTS

      Journal of medicinal chemistry
    16. SAUERBERG P; JEPPESEN L; OLESEN PH; RASMUSSEN T; SWEDBERG MDB; SHEARDOWN MJ; FINKJENSEN A; THOMSEN C; THOGERSEN H; RIMVALL K; WARD JS; CALLIGARO DO; DELAPP NW; BYMASTER FP; SHANNON HE
      MUSCARINIC AGONISTS WITH ANTIPSYCHOTIC-LIKE ACTIVITY - STRUCTURE-ACTIVITY-RELATIONSHIPS OF 1,2,5-THIADIAZOLE ANALOGS WITH FUNCTIONAL DOPAMINE ANTAGONIST ACTIVITY

      Journal of medicinal chemistry
    17. SCHAUS JM; THOMPSON DC; BLOOMQUIST WE; SUSEMICHEL AD; CALLIGARO DO; COHEN ML
      SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF POTENT AND ORALLY-ACTIVE 5-HT4 RECEPTOR ANTAGONISTS - INDAZOLE AND BENZIMIDAZOLONE DERIVATIVES

      Journal of medicinal chemistry
    18. SAUERBERG P; OLESEN PH; SHEARDOWN MJ; RIMVALL K; THOGERSEN H; SHANNON HE; SAWYER BD; WARD JS; BYMASTER FP; DELAPP NW; CALLIGARO DO; SWEDBERG MDB
      CONFORMATIONALLY CONSTRAINED ANALOGS OF THE MUSCARINIC AGONIST IADIAZOL-3-YL)-1,2,5,6-TETRAHYDRO-1-METHYLPYRIDINE - SYNTHESIS, RECEPTOR AFFINITY, AND ANTINOCICEPTIVE ACTIVITY

      Journal of medicinal chemistry
    19. BYMASTER FP; SHANNON HE; RASMUSSEN K; DELAPP NW; MITCH CH; WARD JS; CALLIGARO DO; LUDVIGSEN TS; SHEARDOWN MJ; OLESEN PH; SWEDBERG MDB; SAUERBERG P; FINKJENSEN A
      UNEXPECTED ANTIPSYCHOTIC-LIKE ACTIVITY WITH THE MUSCARINIC RECEPTOR-LIGAND O-1,2,5-THIADIAZOL-4-YL)-1-AZABICYCLO[3.2.1]OCTANE

      European journal of pharmacology
    20. BYMASTER FP; CARTER PA; PETERS SC; ZHANG W; WARD JS; MITCH CH; CALLIGARO DO; WHITESITT CA; DELAPP N; SHANNON HE; RIMVALL K; JEPPESEN L; SHEARDOWN MJ; FINKJENSEN A; SAUERBERG P
      XANOMELINE COMPARED TO OTHER MUSCARINIC AGENTS ON STIMULATION OF PHOSPHOINOSITIDE HYDROLYSIS IN-VIVO AND OTHER CHOLINOMIMETIC EFFECTS

      Brain research
    21. CALLIGARO DO; FAIRHURST J; HOTTEN TM; MOORE NA; TUPPER DE
      THE SYNTHESIS AND BIOLOGICAL-ACTIVITY OF SOME KNOWN AND PUTATIVE METABOLITES OF THE ATYPICAL ANTIPSYCHOTIC AGENT OLANZAPINE (LY170053)

      Bioorganic & medicinal chemistry letters
    22. BYMASTER FP; WHITESITT CA; SHANNON HE; DELAPP N; WARD JS; CALLIGARO DO; SHIPLEY LA; BUELKESAM JL; BODICK NC; FARDE L; SHEARDOWN MJ; OLESEN PH; HANSEN KT; SUZDAK PD; SWEDBERG MDB; SAUERBERG P; MITCH CH
      XANOMELINE - A SELECTIVE MUSCARINIC AGONIST FOR THE TREATMENT OF ALZHEIMERS-DISEASE

      Drug development research
    23. WOLFF MC; BENVENGA MJ; CALLIGARO DO; FULLER RW; GIDDA JS; HEMRICKLUECKE S; LUCOT JB; NELSON DL; OVERSHINER CD; LEANDER JD
      PHARMACOLOGICAL PROFILE OF LY301317, A POTENT AND SELECTIVE 5-HT1A AGONIST

      Drug development research
    24. BYMASTER FP; RASMUSSEN K; CALLIGARO DO; NELSON DL; DELAPP NW; WONG DT; MOORE NA
      IN-VITRO AND IN-VIVO BIOCHEMISTRY OF OLANZAPINE - A NOVEL, ATYPICAL ANTIPSYCHOTIC DRUG

      The Journal of clinical psychiatry
    25. PHEBUS LA; JOHNSON KW; ZGOMBICK JM; GILBERT PJ; VANBELLE K; MANCUSO V; NELSON DLG; CALLIGARO DO; KIEFER AD; BRANCHEK TA; FLAUGH ME
      CHARACTERIZATION OF LY344864 AS A PHARMACOLOGICAL TOOL TO STUDY 5-HT1F RECEPTORS - BINDING AFFINITIES, BRAIN PENETRATION AND ACTIVITY IN THE NEUROGENIC DURAL INFLAMMATION MODEL OF MIGRAINE

      Life sciences
    26. WARD JS; MERRITT L; STRATFORD R; BROWN TJ; WIJAYARATNE R; SZEWCZYK SP; CALLIGARO DO; BYMASTER FP; SHANNON HE; MITCH CH; JOHNSON DW; WIKEL JH; OLESEN MJ; SHEARDOWN MJ; SWEDBERG MDB; SAUERBERG P
      THE TETRAHYDROPYRIDINE RING CONFERS OPTIMAL M(1) SELECTIVITY AND BLOOD-BRAIN-BARRIER PENETRATION AMONG HEXYLOXY-1,2,5-THIADIAZOLE AZACYCLES

      Life sciences
    27. SWEDBERG MDB; SHANNON HE; SHEARDOWN MJ; KLITGAARD H; BYMASTER FP; WARD JS; MITCH CH; OLESEN PH; ESKESEN K; SUZDAK PD; CALLIGARO DO; SAUERBERG P
      ANTICONVULSANT EFFECTS OF MUSCARINICS

      Life sciences
    28. SHANNON HE; WOMER DE; BYMASTER FP; CALLIGARO DO; DELAPP NC; MITCH CH; WARD JS; WHITESITT CA; SWEDBERG MDB; SHEARDOWN MJ; FINKJENSEN A; OLESEN PH; RIMVALL K; SAUERBERG P
      IN-VIVO PHARMACOLOGY OF BUTYLTHIO[2.2.2] (LY297802 NNC11-1053), AN ORALLY ACTING ANTINOCICEPTIVE MUSCARINIC AGONIST/

      Life sciences
    29. SWEDBERG MDB; SHEARDOWN MJ; SAUERBERG P; OLESEN PH; SUZDAK PD; HANSEN KT; BYMASTER FP; WARD JS; MITCH CH; CALLIGARO DO; DELAPP NW; SHANNON HE
      BUTYLTHIO[2.2.2] (NNC 11-1053 LY297802) - AN ORALLY-ACTIVE MUSCARINICAGONIST ANALGESIC/

      The Journal of pharmacology and experimental therapeutics
    30. SHANNON HE; SHEARDOWN MJ; BYMASTER FP; CALLIGARO DO; DELAPP NW; GIDDA J; MITCH CH; SAWYER BD; STENGEL PW; WARD JS; WONG DT; OLESEN PH; SUZDAK PD; SAUERBERG P; SWEDBERG MDB
      PHARMACOLOGY OF BUTYLTHIO[2.2.2] (LY297802 NNC11-1053) - A NOVEL ANALGESIC WITH MIXED MUSCARINIC RECEPTOR AGONIST AND ANTAGONIST ACTIVITY/

      The Journal of pharmacology and experimental therapeutics
    31. MITCH CH; BROWN TJ; BYMASTER FP; CALLIGARO DO; DIECKMAN D; MERRIT L; PETERS SC; QUIMBY SJ; SHANNON HE; SHIPLEY LA; WARD JS; HANSEN K; OLESEN PH; SAUERBERG P; SHEARDOWN MJ; SWEDBERG MDB; SUZDAK P; GREENWOOD B
      MUSCARINIC ANALGESICS WITH POTENT AND SELECTIVE EFFECTS ON THE GASTROINTESTINAL-TRACT - POTENTIAL APPLICATION FOR THE TREATMENT OF IRRITABLE-BOWEL-SYNDROME

      Journal of medicinal chemistry
    32. BYMASTER FP; NELSON DL; DELAPP NW; LUCAITES VL; WAINSCOTT DB; FALCONE JF; ECKOLS K; FOREMAN MM; CALLIGARO DO
      THE ATYPICAL ANTIPSYCHOTIC OLANZAPINE IS AN ANTAGONIST AT DOPAMINE, SEROTONIN AND MUSCARINIC RECEPTOR SUBTYPES

      Schizophrenia research
    33. BYMASTER FP; CALLIGARO DO; FALCONE JF; MARSH RD; MOORE NA; TYE NC; SEEMAN P; WONG DT
      RADIORECEPTOR BINDING PROFILE OF THE ATYPICAL ANTIPSYCHOTIC OLANZAPINE

      Neuropsychopharmacology
    34. COHEN ML; BLOOMQUIST W; SCHAUS JM; THOMPSON DC; SUSEMICHEL AD; CALLIGARO DO; COHEN I
      LY353433, A POTENT, ORALLY EFFECTIVE, LONG-ACTING 5-HT4 RECEPTOR ANTAGONIST - COMPARISON TO CISAPRIDE AND RS23597-190

      The Journal of pharmacology and experimental therapeutics
    35. MEYER JA; LASKA DA; CALLIGARO DO
      DETECTION OF MUSCARINIC ACETYLCHOLINE-RECEPTORS IN THE RAT-KIDNEY USING NESTED PCR

      Molecular biology of the cell
    36. FOREMAN MM; FULLER RW; LEANDER JD; NELSON DL; CALLIGARO DO; LUCAITES VL; WONG DT; ZHANG L; BARRETT JE; SCHAUS JM
      PHARMACOLOGICAL CHARACTERIZATION OF ENANTIOMERS OF 8-THIOMETHYL-2-(DI-N-PROPYLAMINO)TETRALIN, POTENT AND SELECTIVE 5-HT1A RECEPTOR AGONISTS

      Drug development research
    37. SAUERBERG P; OLESEN PH; SHEARDOWN MJ; SUZDAK PD; SHANNON HE; BYMASTER FP; CALLIGARO DO; MITCH CH; WARD JS; SWEDBERG MDB
      MUSCARINIC AGONISTS AS ANALGESICS - ANTINOCICEPTIVE ACTIVITY VERSUS M(1) ACTIVITY - SAR OF ALKYLTHIO-TZTPS AND RELATED 1,2,5-THIADIAZOLE ANALOGS

      Life sciences
    38. WARD JS; MERRITT L; CALLIGARO DO; BYMASTER FP; SHANNON HE; SAWYER BD; MITCH CH; SHEARDOWN MJ; OLESEN PH; SUZDAK PD; SWEDBERG MDB
      3-(3-HEXYLOXYPYRAZINYL) QUINUCLIDINE AS A FUNCTIONALLY SELECTIVE M(1)AGONIST

      Life sciences
    39. MITCH CH; BYMASTER FP; CALLIGARO DO; QUIMBY SJ; SAWYER BD; WARD JS; OLESEN PH; SAUERBERG P; SHEARDOWN MJ; SUZDAK PD; SWEDBERG M; SHANNON HE
      SIDE-CHAIN STERIC BULK AND MUSCARINIC AGONIST SAR IN ALKOXY-TZTPS

      Life sciences
    40. BYMASTER FP; FALCONE JF; SHANNON HE; CALLIGARO DO
      ARACHIDONIC-ACID RELEASE BY MUSCARINIC AGENTS IN CELL-LINES TRANSFECTED WITH MUSCARINIC RECEPTORS

      Life sciences
    41. SHANNON HE; BYMASTER FP; CALLIGARO DO; MITCH CH; SAWYER BD; WARD JS; SHEARDOWN MJ; OLESEN PH; SAUERBERG P; SUZDAK PD; SWEDBERG MDB
      IN-VITRO PHARMACOLOGY OF THE MUSCARINIC ANALGESIC LY297802 NNC111053/

      Life sciences
    42. SWEDBERG MDB; SHEARDOWN MJ; SAUERBERG P; OLESEN P; SUZDAK PD; BYMASTER FP; WARD JS; MITCH CH; CALLIGARO DO; SHANNON HE
      NNC-11-1053 LY-297802 - AN ANTINOCICEPTIVE ORALLY ACTING MUSCARINIC AGONIST IN MOUSE AND RAT

      Life sciences
    43. GITTER BD; BRUNS RF; HOWBERT JJ; WATERS DC; THRELKELD PG; COX LM; NIXON JA; LOBB KL; MASON NR; STENGEL PW; COCKERHAM SL; SILBAUGH SA; GEHLERT DR; SCHOBER DA; IYENGAR S; CALLIGARO DO; REGOLI D; HIPSKIND PA
      PHARMACOLOGICAL CHARACTERIZATION OF LY303870 - A NOVEL, POTENT AND SELECTIVE NONPEPTIDE SUBSTANCE-P (NEUROKININ-1) RECEPTOR ANTAGONIST

      The Journal of pharmacology and experimental therapeutics
    44. WARD JS; MERRITT L; CALLIGARO DO; BYMASTER FP; SHANNON HE; SAWYER BD; MITCH CH; DEETER JB; PETERS SC; SHEARDOWN MJ; OLESEN PH; SWEDBERG MDB; SAUERBERG P
      FUNCTIONALLY SELECTIVE M(1) MUSCARINIC AGONISTS .3. SIDE-CHAINS AND AZACYCLES CONTRIBUTING TO FUNCTIONAL MUSCARINIC SELECTIVITY AMONG PYRAZINYLAZACYCLES

      Journal of medicinal chemistry
    45. WARD JS; MERRITT L; BYMASTER FP; CALLIGARO DO
      ISOARECOLONES AND ARECOLONES - SELECTIVE CENTRAL NICOTINIC AGONISTS THAT CROSS THE BLOOD-BRAIN-BARRIER

      Bioorganic & medicinal chemistry letters
    46. MITCH CH; BYMASTER FP; CALLIGARO DO; QUIMBY SJ; SCHOEPP DD; WONG DT; SHANNON HE
      MUSCARINIC ANTAGONIST ACTIVITY OF (5-ALKOXY-OXAZOL-2-YL)-1,2,5,6-TETRAHYDROPYRIDINES

      Bioorganic & medicinal chemistry letters
    47. MITCH CH; BYMASTER FP; CALLIGARO DO; QUIMBY SJ; SAWYER BD; SHANNON HE; WARD JS; OLESEN PH; SAUERBERG P; SHEARDOWN MJ; SUZDAK PD
      XANOMELINE - A POTENT AND SELECTIVE M1 MUSCARINIC AGONIST IN-VITRO

      Neurobiology of aging
    48. COHEN ML; KURZ KD; FULLER RW; CALLIGARO DO
      COMPARATIVE 5-HT2-RECEPTOR ANTAGONIST ACTIVITY OF AMESERGIDE AND ITS ACTIVE METABOLITE 4-HYDROXYAMESERGIDE IN RATS AND RABBITS

      Journal of Pharmacy and Pharmacology
    49. FOREMAN MM; FULLER RW; RASMUSSEN K; NELSON DL; CALLIGARO DO; ZHANG L; BARRETT JE; BOOHER RN; PAGET CJ; FLAUGH ME
      PHARMACOLOGICAL CHARACTERIZATION OF LY293284 - A 5-HT1A RECEPTOR AGONIST WITH HIGH POTENCY AND SELECTIVITY

      The Journal of pharmacology and experimental therapeutics
    50. SHANNON HE; BYMASTER FP; CALLIGARO DO; GREENWOOD B; MITCH CH; SAWYER BD; WARD JS; WONG DT; OLESEN PH; SHEARDOWN MJ; SWEDBERG MDB; SUZDAK PD; SAUERBERG P
      XANOMELINE - A NOVEL MUSCARINIC RECEPTOR AGONIST WITH FUNCTIONAL SELECTIVITY FOR M(1) RECEPTORS

      The Journal of pharmacology and experimental therapeutics
    51. BYMASTER FP; WONG DT; MITCH CH; WARD JS; CALLIGARO DO; SCHOEPP DD; SHANNON HE; SHEARDOWN MJ; OLESEN PH; SUZDAK PD; SWEDBERG MDB; SAUERBERG P
      NEUROCHEMICAL EFFECTS OF THE M(1) MUSCARINIC AGONIST XANOMELINE (LY246708 NNC11-0232)/

      The Journal of pharmacology and experimental therapeutics
    52. ORNSTEIN PL; ARNOLD MB; AUGENSTEIN NK; DEETER JB; LEANDER JD; LODGE D; CALLIGARO DO; SCHOEPP DD
      UNUSUAL STEREOCHEMICAL PREFERENCES OF DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID COMPETITIVE NMDA ANTAGONISTS

      Bioorganic & medicinal chemistry letters
    53. ESHLEMAN AJ; CALLIGARO DO; ELDEFRAWI ME
      ALLOSTERIC REGULATION BY SODIUM OF THE BINDING OF [H-3] COCAINE AND [H-3] GBR-12935 TO RAT AND BOVINE STRIATA

      Membrane biochemistry
    54. FOREMAN MM; FULLER RW; LEANDER JD; BENVENGA MJ; WONG DT; NELSON DL; CALLIGARO DO; SWANSON SP; LUCOT JB; FLAUGH ME
      PRECLINICAL STUDIES ON LY228729 - A POTENT AND SELECTIVE SEROTONIN(1A) AGONIST

      The Journal of pharmacology and experimental therapeutics
    55. MCQUAID LA; SMITH ECR; LODGE D; PRALONG E; JONES MG; BOND A; SCHOEPP DD; TRUE RA; CALLIGARO DO; OMALLEY PJ
      3-PHENYL-4-HYDROXYQUINOLIN-2(1H)-ONES - POTENT AND SELECTIVE ANTAGONISTS AT THE STRYCHNINE-INSENSITIVE GLYCINE SITE ON THE N-METHYL-D-ASPARTATE RECEPTOR COMPLEX

      Journal of neurochemistry
    56. CALLIGARO DO; OMALLEY PJ; MONN JA
      BETA-AMYLOID (25-35) OR SUBSTANCE-P STIMULATES [H-3] MK-801 BINDING TO RAT CORTICAL MEMBRANES IN THE PRESENCE OF GLUTAMATE AND GLYCINE

      Journal of neurochemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/05/20 alle ore 08:19:54